US biotech revenues grew 4.9% last year to $53.8 billion, compared to 6.5% in 2010, according to Novel Health Strategies. By biologics class, monoclonal antibodies (mAbs) remained the largest, with sales rising 10.1% to around $20.3 billion. Ten of the 36 FDA-approved mAbs accounted for 86% of sales. The fastest growing major class was hormones, […]
Over the coming four years, the shift to bioplastics will be spurred by Coca-Cola’s desire to produce a renewable bottle from ethylene. The long-term driver will be shale gas production. According to Morgan Stanley, in the best case scenario, the global bioplastics market could expand up to an average of 40% annually through 2020 to […]
The average rate of return (IRR), which is the return companies expect on investment, for 12 major pharmaceutical firms—Pfizer, Roche, Novartis, Sanofi, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Merck, Eli Lilly, Bristol-Myers Squibb, Takeda and Amgen—was 7.2% in 2012, compared with 8.4% in 2011. IRRs were determined by approximating future sales from drugs in Phase III […]
In this month’s “Short-Term Energy Outlook,” the US Energy Information Administration (EIA) predicted that global liquid fuel and crude oil demand will increase 0.9% in 2012 and 1.0% in 2013 to 89.9 million barrels per day (bpd). The supply of global liquid fuel and crude oil will increase 2.3% in 2012 and 1.1% in 2013 […]
The CDC’s Next-Generation Sequencing (NGS): Standardization of Clinical Testing workgroup has published recommendations for quality management for next-generation sequencing in clinical labs addressing accuracy in variant calling. The guidelines address test validation, quality control, third-party test assessment and reference materials. The workgroup sought approaches for a quality management system for analytical validity and compliance of […]
Nonculture diagnostic tests for foodborne pathogens, which are becoming more popular and determined nearly 15% of foodborne pathogen outbreaks in 2010, have advantages and disadvantages compared with traditional culture tests. The new nonculture tests, developed by firms such as Abbott Laboratories, BD, Cepheid and Luminex, can detect bacteria that culture tests cannot, such as the […]
Even excluding American Recovery and Reinvestment Act (ARRA) funding, US university spending on R&D continued to grow in fiscal year 2011 (FY11) (ending June 30, 2011). Without ARRA funding, university spending on R&D would have grown 4.0% to $60.9 billion, according to the NSF’s Higher Education Research and Development (HERD) Survey. Including ARRA funds, university […]
Global pharmaceutical sales increased 7.8% to $1.08 trillion in 2011. Pharmaceutical sales in BRIC countries grew 22.6%. The US, Europe’s “Big 5” (France, Germany, Italy, Spain and the UK) and Japan, which PricewaterhouseCoopers classifies as the main pharmaceutical markets, accounted for 59% of sales. PwC predicts that these markets will increase their shares of generics […]
The World Steel Association’s “Short Range Outlook” for 2012 and 2013 forecasts that worldwide apparent steel use, which it defines as deliveries minus net exports of finished steel products, will increase 2.1% in 2012, down from 6.2% growth in 2011. Worldwide apparent steel use is slated to increase 3.2% in 2013 to 1,455 million metric […]
In its 2012 “World Oil Outlook,” OPEC forecasts that world oil demand will reach 92.9 million barrels per day (bpd) by 2016, which is about one million less bpd than it predicted in last year’s report. About 70% of the demand will come from developing Asia. This year, world oil demand is expected to increase […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
